Targeted Therapy

Postoperative Intensity-Modulated Radiation Therapy Impacts Patient Outcomes

September 19, 2022 - A retrospective cohort study using data from the National Cancer Database from January 2004 to December 2019 examined trends in postoperative intensity modulated radiation therapy (IMRT) and the impacts on patient outcomes. Researchers found that, compared to 3D conformal radiation therapy (3DCRT), IMRT improved outcomes for non-small cell lung...

Read More


More Articles

Targeted Therapy for Non-Small Cell Lung Cancer

by Hayden Schmidt

In March, the FDA issued approval for Bristol Meyers Squibb’s immunotherapy, Opdivo, in conjunction with chemotherapy and surgical procedures to treat non-small-cell cancer. Patients given this...

Recent Articles